<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Cancer</journal-id><journal-id journal-id-type="iso-abbrev">BMC Cancer</journal-id><journal-title-group><journal-title>BMC Cancer</journal-title></journal-title-group><issn pub-type="epub">1471-2407</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25886568</article-id><article-id pub-id-type="pmc">4416351</article-id><article-id pub-id-type="publisher-id">1253</article-id><article-id pub-id-type="doi">10.1186/s12885-015-1253-6</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>eCROPS-CA: a systematic approach toward effective and sustainable cancer prevention in rural China</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chai</surname><given-names>Jing</given-names></name><address><email>jingchai82@sina.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Shen</surname><given-names>Xingrong</given-names></name><address><email>1264854421@qq.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Feng</surname><given-names>Rui</given-names></name><address><email>853571123@qq.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Cheng</surname><given-names>Jing</given-names></name><address><email>jing_hp@sina.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Yeji</given-names></name><address><email>ahahcyj@163.com</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Zha</surname><given-names>Zhengqiu</given-names></name><address><email>1061390122@sina.com</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Jia</surname><given-names>Shangchun</given-names></name><address><email>xiao816meng@sina.cn</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Liang</surname><given-names>Han</given-names></name><address><email>1010066583@qq.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Ting</given-names></name><address><email>1252509750@qq.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sha</surname><given-names>Rui</given-names></name><address><email>1214984721@qq.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Shi</surname><given-names>Yong</given-names></name><address><email>295240260@qq.com</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Kaichun</given-names></name><address><email>1350612172@163.com</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wang</surname><given-names>Debin</given-names></name><address><email>dbwang@vip.sina.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><aff id="Aff1"><label>1</label>School of Health Service Management, Anhui Medical University, Hefei, Anhui China </aff><aff id="Aff2"><label>2</label>Department of Literature Review and Analysis, Library of Anhui Medical University, Hefei, Anhui China </aff><aff id="Aff3"><label>3</label>Anhui Center for Disease Control and Prevention, Hefei, Anhui China </aff><aff id="Aff4"><label>4</label>Luan Center for Disease Control and Prevention, Luan, Anhui China </aff><aff id="Aff5"><label>5</label>Collaboration Center for Cancer Control, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui China </aff></contrib-group><pub-date pub-type="epub"><day>8</day><month>4</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>8</day><month>4</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>15</volume><elocation-id>233</elocation-id><history><date date-type="received"><day>29</day><month>5</month><year>2014</year></date><date date-type="accepted"><day>25</day><month>3</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; Chai et al.; licensee BioMed Central. 2015</copyright-statement><license license-type="open-access"><license-p>This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>Effective prevention against cancers depends heavily on sustained individual efforts practicing protective behaviors and avoiding risk factors in a complex sociocultural context, which requires continuous and personalized supports. Contemporary prevention relies primarily on strategies targeting general population with limited attention being paid to individualized approaches. This study tests a novel package called, in acronym of core intervention components, eCROPS-CA that leverages protective behaviors against over 80% leading cancers among high risk individuals via continuous and tailored counseling by village doctors.</p></sec><sec><title>Methods/Design</title><p>The study utilizes a quesi-RCT design involving 4320 high risk individuals selected, via rapid and detailed risk assessments, from about 72,000 farmers aged 35+ in 36 administrative villages randomized into equal intervention and delayed intervention arms. The intervention arm receives baseline and semiannual follow up evaluations plus eCROPS-CA for 5&#x000a0;years; while the control arm, only the baseline and follow-up evaluations for the first 5&#x000a0;years and eCROPS-CA starting from the 6<sup>th</sup> year if the intervention is proved effective. eCROPS-CA comprises electronic supports and supervision (e), counseling cancer prevention (C), recipe for objective behaviors (R), operational toolkit (O), performance-based incentives (P), and screening and assessment (S). Evaluation measures include: incidence and stage of the leading cancers, cancer-related knowledge, attitudes and practices; easy biophysical indicators (e.g., body mass index, blood pressure); intervention compliance, acceptance of the package.</p></sec><sec><title>Discussion</title><p>The prevention package incorporates key success factors in a synergetic way toward cost-effectiveness and long-term sustainability. It targets a set rather than any single cancer; choses village doctors as key solution to the widespread lack of professional manpower in implementing personalized and thus relatively sophisticated prevention; adopts real-time monitoring in reaching continuous improvement; utilizes smart web aids to enable prioritizing complex determinants of objective behaviors, linking counseling sessions happened at different time points and hence delivering highly coordinated prevention; uses 2-stage risk assessment models in identifying high risk individuals so as to focus on the most needed; applies standardized operation procedures in simplifying and smoothing behavior intervention yet ensuring delivery of essential steps and key elements.</p></sec><sec><title>Trials registry</title><p>
<ext-link ext-link-type="uri" xlink:href="http://www.controlled-trials.com/ISRCTN33269053">ISRCTN33269053</ext-link>
</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1186/s12885-015-1253-6) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Cancer</kwd><kwd>Behavior intervention</kwd><kwd>Rural communities</kwd><kwd>Randomized controlled trail</kwd><kwd>Service integration</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2015</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Background</title><p>Cancers have long been a major cause of human death and diseases-adjusted life year (DAILY) loss [<xref ref-type="bibr" rid="CR1">1</xref>]. In 2000, new cancer cases and deaths accounted for 10.1 and 6.2 million respectively worldwide. The same figures increased to 10.86 and 6.73 million by 2002 [<xref ref-type="bibr" rid="CR2">2</xref>]. In 2005, over 7.6 million people died to cancer accounting for 13% of total deaths [<xref ref-type="bibr" rid="CR3">3</xref>]. Predicted cases and deaths will reach about 15 and 10 million by 2020 [<xref ref-type="bibr" rid="CR4">4</xref>]. The most common cancers in terms of incidence rate were lung cancer, breast cancer and colorectal cancer and, in terms of mortality rate, lung cancer, stomach cancer and liver cancer [<xref ref-type="bibr" rid="CR5">5</xref>]. The situation of cancer in China is also most serious. According to China national cancer registration statistics in 2009, standardized cancer incidence rate was 191.72 per 100 thousand and mortality rate, 115.65 [<xref ref-type="bibr" rid="CR6">6</xref>]. Cumulative incidence rate (age 0&#x02013;74) in China added up to 21.99% and total incidence cases, over 2.2 million a year [<xref ref-type="bibr" rid="CR7">7</xref>]. WHO data showed that malignant tumors worldwide took up 5% of total burden caused by all diseases in 2005 [<xref ref-type="bibr" rid="CR8">8</xref>]. More recent investigations revealed that cancers were the first death cause in cities [<xref ref-type="bibr" rid="CR9">9</xref>]. In 2006, direct and indirect economic loss due to the disease was 11.32 and 6.00 billion USD respectively representing 4.67% of total medical cost [<xref ref-type="bibr" rid="CR10">10</xref>].</p><p>The harms of cancers to human health can be attributed to prevention, diagnosis and treatment defects. Accordingly, control strategies against the diseases divide into proactive prevention, early detection and appropriate treatment. Tremendous efforts have been invested on clinical diagnosis and treatment for a long time, but associated survival prolongation is rather limited [<xref ref-type="bibr" rid="CR11">11</xref>-<xref ref-type="bibr" rid="CR16">16</xref>]. As a result, prevention and early detection are gaining recognition. However, contemporary approaches focus primarily on public education (e.g., disseminating prevention information via various mass media) [<xref ref-type="bibr" rid="CR17">17</xref>-<xref ref-type="bibr" rid="CR25">25</xref>], screening service, and drug prevention (e.g., use of folic acid or tamoxifen) and treatment of precancerous conditions (e.g., polyps, Helicobacter pylori infection) [<xref ref-type="bibr" rid="CR26">26</xref>-<xref ref-type="bibr" rid="CR33">33</xref>]. Public education is most cost-effective for communicating general knowledge, but its benefit is restricted largely by the fact that there exists a huge disparity between knowledge and behavior [<xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR28">28</xref>]. Similarly, although a large number of researches have revealed that screening for high-risk groups and some drugs and treatment prevention are highly cost-effective under research conditions, these measures are seldom in use in routine practices of cancer prevention and control [<xref ref-type="bibr" rid="CR28">28</xref>]; even used, the effectiveness often turned out to be far less from expected [<xref ref-type="bibr" rid="CR34">34</xref>-<xref ref-type="bibr" rid="CR40">40</xref>].</p><p>Although the huge gap between the actual application of proven preventions and expectations may be attributed to a variety of reasons, lacking personalized behavior promotion may have plaid an important role [<xref ref-type="bibr" rid="CR41">41</xref>]. Most cancer prevention measures can only work when the target individuals themselves take action. For example, cancer prevention knowledge communicated via mass media needs to be understood, accepted and finally translated into action by intended audiences. Likewise, screening for cancers regularly, treating precancerous lesions and others, all depend heavily on the acceptance and cooperation of the individuals in need of these services. General or non-tailored education and service promotion often fails in initiating or maintaining desired prevention practices due to extreme complexity of the factor system determining these behaviors. On the one hand, the nexus of complex factors makes it hard for ordinary residents to perceive true relationships between prevention measures and cancer incidence and harms. This greatly weakens the motivation for implementing the measures. On the other, effectively changing the outcomes of a complicated behavior determinant system requires integrating multiple measures in a synergetic way. This is to the disadvantage of general &#x0201c;education&#x0201d; and often beyond the ability of ordinary people especially old rural farmers with over 61.8% of illiteracy [<xref ref-type="bibr" rid="CR42">42</xref>]. Similar challenges also perpetuate diabetes-related behavior intervention. In order to promote sustainable lifestyle modifications preventing progression from pre-diabetes to diabetes, we developed an intervention package called eCROPS and tested it in rural Luan, Anhui, China with encouraging early findings [<xref ref-type="bibr" rid="CR43">43</xref>]. This study tires to adapt eCROPS to suit cancer behavior intervention and evaluate its efficacy. This new intervention package (further referred to as eCROPS-CA) targets at multi-types of cancers at the same time and stresses reliance on village doctors, integration of cancer prevention with routine medical service, incorporation of multiple strategies in motivating the involved, theory-guided standardization and assessment-based tailoring, and low cost and sustainability.</p><p>Although there are a few articles documenting behavior intervention against single type cancer using simple measures (e.g., application of telephone or emails in containing tobacco and alcohol consumption after intestinal polyps resection [<xref ref-type="bibr" rid="CR44">44</xref>-<xref ref-type="bibr" rid="CR46">46</xref>]), researches attempting cancer prevention in a systematic way like this are limited. China has a long history of separated systems for disease treatment (medical system) and prevention (CDC system) [<xref ref-type="bibr" rid="CR47">47</xref>]. The CDC system is founded by the government and launches free cancer preventions (primarily mass media education and case registry); while the medical system depends almost solely on fee for service and provides cancer screening, diagnosis and treatment at patients&#x02019; expenses. Although village doctors belong to the medical system, they are not qualified to deliver neither cancer screening nor diagnosis and treatment. So they seldom involve in cancer-related services. The large number of village doctors (over one million) provides enormous potential for reaching far and wide [<xref ref-type="bibr" rid="CR48">48</xref>] and the historical, social and cultural role of them provides necessary professional legitimacy. Chinese people hold strong beliefs that doctors (including village doctors) are respectful and trustworthy because they save lives and that human body is too complex for ordinary people to fully understand and patients should take their doctors&#x02019; advice since they are educated and experienced in dealing with complex health problems [<xref ref-type="bibr" rid="CR49">49</xref>]. Village doctors enjoy easy access to farmers and knew the patients&#x02019; language and level of understanding; while their professional knowledge and experience can greatly facilitate their involvement in cancer intervention and a minimal training can produce highly effective cancer interventionists. More importantly, most cancer prevention service can be arranged to coincide routine medical care which provides a unique teaching moment when health is valued and help from doctors is most needed [<xref ref-type="bibr" rid="CR50">50</xref>].</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Methods/Design</title><sec id="Sec3"><title>Study design</title><p>The study utilizes, after one year and a half piloting, a quesi-RCT (randomized controlled trial) design and involves 4320 high risk individuals selected, via rapid risk assessments (RRA) and detailed risk assessments (DRA), from about 72,000 farmers aged 35 or older in 36 administrative villages randomized into equal intervention and delayed intervention arms. The intervention arm receives baseline and semiannual follow up evaluations plus eCROPS-CA for 5&#x000a0;years; while the control arm, only the same baseline and follow up evaluations for the first 5&#x000a0;years and eCROPS-CA starting from year 6 if the intervention is proved effective.</p></sec><sec id="Sec4"><title>Study aim</title><p>The study aims at demonstrating that eCROPS-CA is effective in preventing leading cancers and high risk individuals in the intervention arm will, compared to those in the delayed intervention condition, show a lower incidence of cancers, improved cancer-related KAP (knowledge, attitudes and practices) and easy-biophysical indicators, and increased use of cancer prevention service. A secondary objective is to establish a sustainable mechanism, in which participating village doctors maintain continuous momentum integrating cancer prevention with routine medical service ever since initiation of this project in resource-poor rural China.</p></sec><sec id="Sec5"><title>Study sample</title><sec id="Sec6"><title>Selection and randomization of villages</title><p>The study involves 36 administrative villages sampled through 3 stages (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Stage 1 classifies all the counties in Anhui province into southern, northern and middle areas. Stage 2 randomly selects 3 counties from each of the areas. Stage 3 draws 4 villages with the largest number of famers from each of the counties and randomizes them into two equal groups (i.e., 18 villages in either the intervention or the delayed intervention arms). All delayed intervention villages within half-day walking distance from any intervention one are re-sampled for avoiding cross contamination. The randomizing proceeds in two steps: each of the 9 county CDCs (centers for disease control and prevention) provides a roster and map of administrate villages with over 4000 resident farmers within its jurisdiction; the eCROPS-CA Technique Group from Anhui Medical University performs randomized selection and grouping.<fig id="Fig1"><label>Figure 1</label><caption><p>
<bold>Study subject sampling and randomization.</bold>
</p></caption><graphic xlink:href="12885_2015_1253_Fig1_HTML" id="d30e511"/></fig></p></sec><sec id="Sec7"><title>Eligibility criteria of participants</title><p>The study recruits both village doctors and their patients. All the accredited village doctors working for the clinics of the selected villages are encouraged to participate. Inclusion criteria of patients include men and women who: are 35&#x000a0;years or older; live in the selected villages for over 6&#x000a0;months per year (a large part of rural farmers migrate to cities for temporary jobs every year); meet the cut point score of RRA (&#x02265; the 70th percentile of RRA score) and DRA (&#x02265; the 80<sup>th</sup> percentile of DRA score). Farmers who have already diagnosed with cancer(s) or mental illness or serious illness or disability are excluded.</p></sec><sec id="Sec8"><title>Sample size</title><p>The study sample size derives from the key assumption expected to check that eCROPS-CA may prevent the leading cancers including stomach, trachea/bronchus/lung, esophagus, liver, colon/rectum/anus, breast, cervix, pancreas, and nasopharynx cancers. Based on our previous research, for a village with over 4000 farmers, about 2000 aged 35+ seek service from the village clinic within one year. The rapid assessment identifies 30% of them (i.e., 600) as tentative risk famers (TRFs) and the detailed assessment in turn, 20% of the TRFs as final risk famers (FRFs). In this way, about 72000 famers from the 36 villages will receive RRA, 21600 will go a step further into DRA and a total of 4320, into intervention and control groups. Our previous small scale investigation observed a total of 34 cases of the 9-cancers out of 296 FRFs in 3&#x000a0;years (872 person-years in total). So the annual incidence rate and the 3&#x000a0;year cumulative incidence rate were 3.90% and 12.20% separately. Given these and suppose: intervention has a moderate effect (20% reduction) in the cumulative incidence rate of the 9-cancers in 5&#x000a0;years; significance level (alpha) is set at 0.05 to avoid a Type I error, and power (1&#x02013;beta), at 95% to avoid a Type II error; c) 5-year follow up attrition is 20%. Therefore, 4320 FRFs should have over 95% chance of detecting significant difference in 5-year cumulative incidence rate of the cancers.</p></sec><sec id="Sec9"><title>Intervention</title><sec id="FPar1"><title>Over view of intervention content and flow</title><p>In addition to existing curative and preventive services, the intervention arm implements eCROPS-CA, where CA stands for cancer while letters in the acronym eCROPS, electronic supports and supervision (e), counseling behavior prevention (C), recipe for objective behaviors (R), operational toolkit (O), performance-based incentives (P), screening and assessment (S) respectively. These components are subject to continuous refinement in accordance with the findings from the semiannual evaluations to be described later especially feedbacks from participating village doctors and farmers. Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref> summarizes the components of the intervention package and their relationships. Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref> depicts the main procedures of the intervention, the logic flows among these procedures and how they fit with traditional medical service at village clinics. While the following subsections provides item-by-item briefings of eCROPS-CA components.<fig id="Fig2"><label>Figure 2</label><caption><p>
<bold>Intervention components and their relationships.</bold>
</p></caption><graphic xlink:href="12885_2015_1253_Fig2_HTML" id="d30e550"/></fig><fig id="Fig3"><label>Figure 3</label><caption><p>
<bold>Logic flow of designed cancer prevention service.</bold>
</p></caption><graphic xlink:href="12885_2015_1253_Fig3_HTML" id="d30e562"/></fig></p></sec><sec id="FPar2"><title>Counseling cancer prevention (C)</title><p>Counseling behavior prevention (C) divides into 3 categories, i.e., risk assessment promotion, objective behavior initiation and objective behavior reinforcement. Risk assessment promotion applies to farmers scored higher than the 70<sup>th</sup> percentile score of RRA and aims at promoting acceptance of DRA. Counseling behavior initiation happens to farmers who have scored higher than the 80<sup>th</sup> percentile score of the DRA yet not experienced the project-designed behavior intervention and tries to raise their awareness of elevated cancer risks and urges them to take action reducing the risks. It proceeds in 5 steps (blue rectangles in Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>): alerting risks and harms; setting objective behaviors; discussing efficacy and benefits; anticipating barriers and problems; providing assistance and supports. Here, objective behavior refers to desired behaviors (such as eating more vegetables and regular self-examination) conducive to cancer prevention. Counseling behavior reinforcement targets follow-up farmers who have received initial behavior change counseling and focuses on reinforcing behavior improvement and solving problems encountered in implementing the changes. It also consists of 5 steps (pink rectangles in Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>): reviewing behavior changes; encouraging improvement; identifying problems; selecting problems; solving problems. All counseling sessions utilizes standard operation procedures (SOPs) to ensure delivery of key elements, though the counselor village doctors are encouraged to make the best use of their own experiences. Development of the SOPs employs similar steps, theories and methods we used in deriving the SOPs for diabetes prevention [<xref ref-type="bibr" rid="CR51">51</xref>,<xref ref-type="bibr" rid="CR52">52</xref>].</p><p>Behavior counseling happens at a monthly (in the first year), bimonthly (in the second year) and quarterly base (in the remaining years). Such arrangement is based on a number of considerations: the counseling need to cover a total of 7 categories of objective behaviors (Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>); a typical village doctor serves about 15 patients a day and has enough spare time to deliver counseling; most village clinics locate within 15&#x000a0;minute walking from the farmers and amid their way for going shopping, sending children to schools etc.; walking to and from village clinics may also be viewed as a way to promote additional physical activities, one of the planned objective behaviors.</p></sec><sec id="FPar3"><title>Recipe for objective behaviors (R)</title><p>Recipe of objective behaviors (R) consists of a complete list of the behaviors this study tries to make its target farmers to practice and rules/tips for doing so in forms of education leaflets and webpages. The list comprises 7 categories: improving diet and nutrition (e.g., more vegetables, less cured foods); increasing physical activities (e.g., work, housework and leisure-time activities); reducing risk behaviors (e.g., smoking, unprotected sex); regulating mood and feeling (e.g., depression, anxiety); seeking help and services (e.g., cancer screening, treatment for pre-cancerous conditions); avoiding environmental carcinogens (e.g., benzene, arsenic); involving friends and relatives (e.g., spouse or colleagues in exercises). For each of these objective behaviors, the recipe provides bulleted items telling: why one should practice the behavior; how to initiate and maintain the behavior; what problems may encounter in implementing the behavior; how to solve the problems.</p></sec><sec id="FPar4"><title>Operational toolkit (O)</title><p>Operational toolkit (O) gears with a series of operational tools including: &#x0201c;reference table/lists&#x0201d; of cross-links between cancers and risk factors, contacts of related referral services etc.; &#x0201c;worksheets&#x0201d; for planning diet, physical activities, follow up visits etc.; &#x0201c;easy calculators&#x0201d; for estimating body mass index (BMI), diet calorie intake or glycemic index, activity calorie consumption etc.; and &#x0201c;visual-aids&#x0201d; for demonstrating composition of risk factors and trends in estimated cancer risk score, BMI,blood pressure, plasma glucose etc. All these tools are easily accessible by participating doctors and farmers via the project website at any time (Figure&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>).<fig id="Fig4"><label>Figure 4</label><caption><p>
<bold>Sample applications of project operational toolkit viewed using a smart phone.</bold>
</p></caption><graphic xlink:href="12885_2015_1253_Fig4_HTML" id="d30e616"/></fig></p></sec><sec id="FPar5"><title>Performance-based incentives (P)</title><p>Performance-based incentives (P) aim at generating adequate momentum for village doctors to deliver designed intervention through financial reimbursement, prevention requirement, continuing education credit, and membership of Integrated Service Network. More specifically, participating doctors meeting set performance standard get reimbursed at about $3.5 per case-year; involvement in the cancer prevention satisfies a policy, newly issued by the local health authorities due to the project, mandating that all practicing village doctors must deliver a minimum of prevention service so as to qualify future license renewal; completion of the project training and case reporting and analysis entails awarding of continuing education credits required by annual performance appraisal. In addition, participation in the project automatically gains a membership of the Integrated Service Network that enjoys: free access to periodical circulation of a Newsletter and web-based forum for sharing cases and experiences maintained by members of the Network; technical assistance from higher level network members including members from prefecture and province level hospitals; dual referral privilege within the Network.</p></sec><sec id="FPar6"><title>Screening and assessment (S)</title><p>Screening and assessment (S) utilizes a two stage strategy, i.e., RRA (10 to 15&#x000a0;minutes) followed by DRA (20 to 35&#x000a0;minutes), and serves 3-fold purposes: to identify high-risk farmers and thus deliver focused intervention; to inform personalized and outcome-oriented behavior intervention; to enable intervention quality monitoring and supervision. RRA covers all visiting patients aged 35+ who have not received the same assessment in the last two years. It solicits information about risks of developing cancers for individual patients using a web-based structured questionnaire (Additional file <xref rid="MOESM1" ref-type="media">1</xref>, Part A) and automatically produces, via the web-based system, a risk score for the patient. If the RRA score is higher than the preset RRA cut point mentioned earlier, a DRA follows which expands the scope and detail of the information collected via the RRA using again a web-based structured instrument (Additional file <xref rid="MOESM1" ref-type="media">1</xref>, Part B). DRA also automatically generates a risk score for each patient and if this DRA score is higher than the preset DRA cut point, the patient is eligible to receive further intervention and evaluate on. Calculation of both the RRA and DRA risk scores utilizes a two-stage weighing system (Additional file <xref rid="MOESM1" ref-type="media">1</xref>, Part C).</p></sec><sec id="FPar7"><title>Electronic supports and supervision (e)</title><p>Electronic supports and supervision (e) adapt from the smart web-aid we developed for preventing diabetes [<xref ref-type="bibr" rid="CR52">52</xref>] and consists of user-friendly education and learning assistance (ELA, e<sub>1</sub>), high-risk individual management system (HIMS, e<sub>2</sub>), and effectiveness and quality monitoring (EQM, e<sub>3</sub>). The HIMS provides doctors with a whole set of helps ranging from maintaining a dataset of high-risk farmers, scheduling and reminding (via land or cell-phones) follow-up intervention services, reviewing individual performance and intervention history, to facilitating (via built-in standard operating procedures) delivery of intervention counseling etc. The ELA for village doctors comprises: web-based tutorial on implementing the project prevention in both video and textile formats; typical case studies in which participating village doctors are requested to record and post at least 1 bottom case (in terms of compliance with planned behavior changes) bimonthly on a Web-Forum and then experts and other village doctors share experiences coping with similar cases; video and pictorial materials about cancer and its prevention suitable for displaying at village clinics for attending high-risk patients. The EQM assists project managers to: solicit relevant data for monitoring cancer behavior intervention; identify deviation from planned deliverables; and feedback monitoring findings.</p></sec></sec><sec id="Sec10"><title>Control</title><p>The control arm maintains existing curative and preventive services without adding any prevention component included in eCROPS-CA except for RRA and DRA.</p></sec></sec><sec id="Sec11"><title>Study and data integrity</title><p>The study design follows the CONSORT (Consolidated Standards of Reporting Trials) statement [<xref ref-type="bibr" rid="CR53">53</xref>].</p></sec><sec id="Sec12"><title>Measures</title><p>The study uses 5 types of outcome and process measures to assess intervention efficacy and sustainability, i.e., diagnosed type and stage of cancers, cancer-related KAP (knowledge, attitudes and practices), easy biophysical indicators, intervention compliance and acceptance of eCROPS-CA (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). In addition, the study also collects related social demographic variables e.g., age, gender, ethnicity, migration patterns, marital status, education.<table-wrap id="Tab1"><label>Table 1</label><caption><p>
<bold>Main outcome measures for assessing intervention efficacy</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Domain of measures</th><th>Specific indicators</th></tr></thead><tbody><tr><td>A) Cases and stages of cancers diagnosed</td><td>Cases of the 9 cancers newly diagnosed from last assessment; date and evidence of diagnosis; stage of the cancers at diagnosis.</td></tr><tr><td>B) Related knowledge, attitudes and practices</td><td>Knowledge about susceptibility and seriousness of cancer; knowledge about effectiveness of practicing each of the objective behaviors; knowledge about benefits of practicing each of the objective behaviors; knowledge about barriers to practicing each of the objective behaviors; knowledge about strategies/techniques for coping with each of the barriers to practicing each of the objective behaviors; practice of each of the objective behaviors.</td></tr><tr><td>C) Easy biophysical indicators</td><td>Body height; body weight; waist circumstance; hip circumstance; systolic/diastolic blood pressure, fasting plasma glucose etc.</td></tr><tr><td>D) Intervention compliance</td><td>Proportion of eligible patients who complete detailed risk assessment; proportion of eligible patients who attend at least 10 counseling sessions in the first year of the intervention and at least 5 sessions in each of the following years; proportion of village clinic doctors who complete at least 90% of the counseling sessions assigned.</td></tr><tr><td>E) Acceptance of eCROPS-CA</td><td>Acceptance, beliefs and comments about the eCROPS-CA as a whole and specific components voiced by key informants, e.g., participating village doctors, farmers and project managers and supervisors.</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec13"><title>Evaluation time points</title><p>Evaluation of the intervention package happens at baseline and semiannually thereafter. Each round of field data collection lasts for one week scheduled at the week before doctor training and the last week of the 6<sup>th</sup>, 12<sup>th</sup>, 18<sup>th</sup>, 24<sup>th</sup>, 30<sup>th</sup>, 36<sup>th</sup>, 42<sup>th</sup>, 48<sup>th</sup>, 54<sup>th</sup>, and 60<sup>th</sup> month after the baseline respectively. Both intervention and control arms receive identical evaluation using same questionnaire, same field data collectors and same assessment time points.</p></sec><sec id="Sec14"><title>Data analyses</title><p>Analysis of quantitative data proceeds in 3 steps. Initial analysis centers on descriptive summaries intended to examine major deliverables and patterns of the various measurements (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and Figure&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>) and check for normality of the continuous variables. Necessary transformations are explored and selected, if necessary, to induce approximate normality. The next step estimates, using two-sided test of the null hypothesis, the power of differences between the intervention and delayed intervention groups and between different time points in terms of the outcome measures. Considering the possibility that the prevention package may cause earlier cancer diagnosis in the intervention than in the delayed arm and thus results in reduced difference in cancer incidence between the two arms, comparison in composition of cancer stages parallels comparison in cancer incidence rate between the two groups. The last step explores multivariate models, e.g., regression models between: cancer occurrence and various factors assessed via RRA and DRA; objective behaviors and knowledge, attitudes, self-efficacies, prevention services etc.; prevention service compliance and cancer risk scores, age, gender, education, service quality etc. Analysis of qualitative interviews with key informants (e.g., village doctors, farmers, intervention supervisors, project managers) adopts similar perspectives and methods as that used in one of our previous studies [<xref ref-type="bibr" rid="CR52">52</xref>].<fig id="Fig5"><label>Figure 5</label><caption><p>
<bold>Sample outcome measures between intervention and control arms (Red lines represent measures for intervention arm and blue lines, delayed intervention arm).</bold>
</p></caption><graphic xlink:href="12885_2015_1253_Fig5_HTML" id="d30e792"/></fig></p></sec><sec id="Sec15"><title>Ethical considerations</title><p>The study involves recruitment, intervention and assessment of patients and village doctors. So it adheres to rigorous human subject protection principles. The study protocol had been reviewed and approved by the Biomedical Ethics Committee of Anhui Medical University (reference number: 20140271). Participation of patients and doctors are voluntary. And written informed consent is sought from all participants.</p></sec></sec><sec id="Sec16" sec-type="discussion"><title>Discussion</title><p>The cancer prevention package (eCROPS-CA) this study tries to test and refine has several important features. First, eCROPS-CA incorporates key success factors in a synergetic way toward cost-effectiveness and long-term sustainability and targets at a set rather than a single type of cancers. Multiple types of cancers pose problems for interpreting the ultimate outcome (i.e., cancer incidence reduction) of the intervention since, for instance, avoidance of same cases of breast cancer and lung cancer may have different meanings. However, most cancers share similar causes. For example, inadequate intake of vegetables is not only linked with gastric cancer but also colorectal cancer, breast cancer, liver cancer and lung cancer etc. [<xref ref-type="bibr" rid="CR54">54</xref>,<xref ref-type="bibr" rid="CR55">55</xref>]. This suggests that increasing vegetable intake may prevent a number of cancers and intervention packages against multiple cancers may prove to be more cost-effective than that focusing on a single cancer. Similarly, comprehensive approaches make it hard to distinguish the effects of specific components within a package and thus selecting and combining elements into a working whole becomes vital yet challenging. In order to properly tackle this challenge, eCROPS-CA adopts soft systems thinking which originates from software development and views all elements in an interactive and holistic way [<xref ref-type="bibr" rid="CR56">56</xref>]. More specifically, eCROPS-CA first sets an ultimate goal of effective, low cost and sustainable interventions against common cancers and then identifies key success factors for reaching this end, devices necessary intervention components satisfying all these factors, and finally forms a practical whole. This development strategy should ensure that the whole intervention package is goal-oriented and each component included has clear and important contributions to the ultimate goal.</p><p>Second, eCROPS-CA adopts real-time effectiveness and quality monitoring in leveraging continuous improvement. Here, &#x0201c;real-time&#x0201d; means that the majority of data required by the monitoring derive from ad hoc records of routine prevention rather than from separate data reporting or collection. For example, during counseling sessions, the smart web aid always proposes step-wise topics for discussion, each of which follows a checkbox list that enables the counselor doctor to record essential items about what the counselee patient has already know or done. And only when the doctor has clicked all the required checkboxes, can he/she proceed with the next step. This real-time recoding not only saves costs but also enhances accuracy of data collection. More importantly, although managerial monitoring relies heavily on real-time data, the primary purpose of all these recordings is to help the village doctors to improve their prevention service and performance. Taking the above example again, the checkboxes are designed mainly for branching and informing next step counseling rather than managerial monitoring. This reduces potential conflict of interests that perpetuates most self-report-based project monitoring since the benefits (e.g., better tailored service, earlier detection and correction of weaknesses) over-weight the dis-benefits (e.g., temporary or partial reduction in performance assessment) for maintaining high data collection fidelity. In addition, the monitoring stresses easy biophysical indicators (e.g., BMI, blood pressure, plasma glucose) which incur almost no pain and the least cost for both service providers and receivers and all of these indicators are closely linked to the health of high risk individuals on the one hand and the performance of the village doctors on the other. This clear relationship makes the monitoring most convincing for all stakeholders.</p><p>Third, eCROPS-CA utilizes powerful recording, retrieving and processing abilities of computer systems to enable prioritizing complex determinants of objective behaviors, linking counseling sessions happened at different time points and hence delivering highly coordinated prevention services. Although computers and internet are available at most village clinics in Anhui and throughout China and most village doctors have elementary computer literacy [<xref ref-type="bibr" rid="CR57">57</xref>], there are considerable fears about the ability of village doctors in rural China to use computerized systems. Our preliminary researches suggest that electronic applications are both acceptable and manageable to doctors even in resource-poor areas [<xref ref-type="bibr" rid="CR43">43</xref>,<xref ref-type="bibr" rid="CR52">52</xref>]. Given the user-friendly education and learning assistance, all the village doctors learned to use the system at a one day orientation workshop. Then, after 2 to 4&#x000a0;weeks of self-practice, encouragement, and problem inquiring and answering, most village doctors became confident users. By examining this protocol, one can easily find that eCROPS-CA is almost infeasible without the &#x0201c;e&#x0201d; component. If proved effective, this study should inform leveraging electronic supports in exploring new cancer prevention models and techniques.</p><p>Other characteristics of eCROPS-CA include: it uses stage-wise risk assessment models in identifying high risk individuals so as to greatly narrow down the scale of intervention and focus scarce resources on the most needed; it applies standardized operation procedures (SOPs) derived from proven theories (e.g., health belief model, motivational interviewing) and best practices in simplifying and smoothing behavior intervention yet ensuring delivery of essential steps and key success elements; it employs consecutive assessment and feedbacks in tailoring interventions to individual&#x02019;s dynamic risk status and influence factors. These will be further addressed separately.</p></sec></body><back><app-group><app id="App1"><sec id="Sec17"><title>Additional file</title><p>
<media position="anchor" xlink:href="12885_2015_1253_MOESM1_ESM.docx" id="MOESM1"><label>Additional file 1:</label><caption><p>
<bold>Detailed risk assessment instrument and scoring systems.</bold>
</p></caption></media>
</p></sec></app></app-group><fn-group><fn><p><bold>Competing interests</bold></p><p>The authors declare that they have no competing interests.</p></fn><fn><p><bold>Authors&#x02019; contributions</bold></p><p>JChai and XS contributed equally in conceiving this project, facilitating protocol and SOPs development, and drafting this manuscript. RF and JCheng designed the RRA/DRA instruments and evaluation measures. HL, TZ and RS developed the web aid. KL and YS lead the development of performance-based incentives. YC, ZZ and SJ facilitated project implementation. DW provided expertise for overall design of the study, and revised and finalized the manuscript. All authors read and approved the final manuscript.</p></fn><fn><p><bold>Authors&#x02019; information</bold></p><p>Jing Chai and Xingrong Shen are equal first authors.</p></fn></fn-group><ack><title>Acknowledgements</title><p>Development of the primitive protocol was supported by the Natural Science Foundation of China (grant number: 81172201). Refinement and implementation of the protocol is lead and supported by Collaboration Center for Cancer Control of Anhui Medical University, Anhui and Luan Center for Diseases Control and Prevention.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name></person-group><article-title>Global burden of cancer</article-title><source>Yale J Biol Med</source><year>2006</year><volume>79</volume><issue>3&#x02013;4</issue><fpage>85</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">17940618</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parkin</surname><given-names>DM</given-names></name><name><surname>Bray</surname><given-names>F</given-names></name><name><surname>Ferlay</surname><given-names>J</given-names></name><name><surname>Pisani</surname><given-names>P</given-names></name></person-group><article-title>Estimating the world cancer burden: GLOBOACN 2000</article-title><source>Int J Cancer</source><year>2001</year><volume>94</volume><issue>2</issue><fpage>153</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1002/ijc.1440</pub-id><pub-id pub-id-type="pmid">11668491</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parkin</surname><given-names>DM</given-names></name><name><surname>Bray</surname><given-names>F</given-names></name><name><surname>Ferlay</surname><given-names>J</given-names></name><name><surname>Pisani</surname><given-names>P</given-names></name></person-group><article-title>Global cancer statistics, 2002</article-title><source>CA Cancer J Clin</source><year>2005</year><volume>55</volume><issue>25</issue><fpage>74</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.3322/canjclin.55.2.74</pub-id><pub-id pub-id-type="pmid">15761078</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parkin</surname><given-names>DM</given-names></name></person-group><article-title>Global cancer statistics in the year 2000</article-title><source>Lancet Oncol</source><year>2001</year><volume>2</volume><issue>9</issue><fpage>533</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/S1470-2045(01)00486-7</pub-id><pub-id pub-id-type="pmid">11905707</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferlay</surname><given-names>J</given-names></name><name><surname>Shin</surname><given-names>HR</given-names></name><name><surname>Bray</surname><given-names>F</given-names></name><name><surname>Forman</surname><given-names>D</given-names></name><name><surname>Mathers</surname><given-names>C</given-names></name><name><surname>Parkin</surname><given-names>DM</given-names></name></person-group><article-title>Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008</article-title><source>Int J Cancer</source><year>2010</year><volume>127</volume><fpage>2893</fpage><lpage>917</lpage><pub-id pub-id-type="doi">10.1002/ijc.25516</pub-id><pub-id pub-id-type="pmid">21351269</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>SW</given-names></name><name><surname>Lei</surname><given-names>ZL</given-names></name><name><surname>Li</surname><given-names>GL</given-names></name><name><surname>Zou</surname><given-names>XN</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>WQ</given-names></name></person-group><article-title>A report of Cancer Incidence and Mortality from 34 Cancer Registries in China (in Chinese), 2006</article-title><source>China Cancer</source><year>2010</year><volume>19</volume><issue>6</issue><fpage>356</fpage><lpage>65</lpage></element-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">China Ministry of Health. China Annual Health Statistics. China Union Medical University Press; 2007.</mixed-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>World Health Statistics</source><year>2006</year><publisher-loc>Geneva</publisher-loc><publisher-name>WHO</publisher-name></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>China Ministry of Health</collab></person-group><source>China Third National Death Cause Survey</source><year>2008</year><publisher-loc>Beijing</publisher-loc><publisher-name>China Union Medical University Press</publisher-name></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>QL</given-names></name></person-group><source>Malignant disease burden research. MD thesis</source><year>2009</year><publisher-loc>Xiamen</publisher-loc><publisher-name>Xiamen University</publisher-name></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paz-Ares</surname><given-names>LG</given-names></name><name><surname>de Marinis</surname><given-names>F</given-names></name><name><surname>Dediu</surname><given-names>M</given-names></name><name><surname>Thomas</surname><given-names>M</given-names></name><name><surname>Pujol</surname><given-names>JL</given-names></name><name><surname>Bidoli</surname><given-names>P</given-names></name><etal/></person-group><article-title>PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer</article-title><source>J Clin Oncol</source><year>2013</year><volume>31</volume><issue>23</issue><fpage>2895</fpage><lpage>902</lpage><pub-id pub-id-type="doi">10.1200/JCO.2012.47.1102</pub-id><pub-id pub-id-type="pmid">23835707</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Cutsem</surname><given-names>E</given-names></name><name><surname>Tabernero</surname><given-names>J</given-names></name><name><surname>Lakomy</surname><given-names>R</given-names></name><name><surname>Prenen</surname><given-names>H</given-names></name><name><surname>Prausov&#x000e1;</surname><given-names>J</given-names></name><name><surname>Macarulla</surname><given-names>T</given-names></name><etal/></person-group><article-title>Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen</article-title><source>J Clin Oncol</source><year>2012</year><volume>30</volume><issue>28</issue><fpage>3499</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1200/JCO.2012.42.8201</pub-id><pub-id pub-id-type="pmid">22949147</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fizazi</surname><given-names>K</given-names></name><name><surname>Scher</surname><given-names>HI</given-names></name><name><surname>Molina</surname><given-names>A</given-names></name><name><surname>Logothetis</surname><given-names>CJ</given-names></name><name><surname>Chi</surname><given-names>KN</given-names></name><name><surname>Jones</surname><given-names>RJ</given-names></name><etal/></person-group><article-title>COU-AA-301 Investigators: Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, lacebo-controlled phase 3 study</article-title><source>Lancet Oncol</source><year>2012</year><volume>13</volume><issue>10</issue><fpage>983</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/S1470-2045(12)70379-0</pub-id><pub-id pub-id-type="pmid">22995653</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scagliotti</surname><given-names>GV</given-names></name><name><surname>Hirsh</surname><given-names>V</given-names></name><name><surname>Siena</surname><given-names>S</given-names></name><name><surname>Henry</surname><given-names>DH</given-names></name><name><surname>Woll</surname><given-names>PJ</given-names></name><name><surname>Manegold</surname><given-names>C</given-names></name><etal/></person-group><article-title>Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study</article-title><source>J Thorac Oncol</source><year>2012</year><volume>7</volume><issue>12</issue><fpage>1823</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1097/JTO.0b013e31826aec2b</pub-id><pub-id pub-id-type="pmid">23154554</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Cutsem</surname><given-names>E</given-names></name><name><surname>K&#x000f6;hne</surname><given-names>CH</given-names></name><name><surname>L&#x000e1;ng</surname><given-names>I</given-names></name><name><surname>Folprecht</surname><given-names>G</given-names></name><name><surname>Nowacki</surname><given-names>MP</given-names></name><name><surname>Cascinu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status</article-title><source>J Clin Oncol</source><year>2011</year><volume>29</volume><issue>15</issue><fpage>2011</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1200/JCO.2010.33.5091</pub-id><pub-id pub-id-type="pmid">21502544</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bamias</surname><given-names>A</given-names></name><name><surname>Bamia</surname><given-names>C</given-names></name><name><surname>Zagouri</surname><given-names>F</given-names></name><name><surname>Kostouros</surname><given-names>E</given-names></name><name><surname>Kakoyianni</surname><given-names>K</given-names></name><name><surname>Rodolakis</surname><given-names>A</given-names></name><etal/></person-group><article-title>Improved survival trends in platinum-resistant patients with advanced ovarian, fallopian or peritoneal cancer treated with first-line paclitaxel/platinum chemotherapy: the impact of novel agents</article-title><source>Oncology</source><year>2013</year><volume>84</volume><issue>3</issue><fpage>158</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1159/000341366</pub-id><pub-id pub-id-type="pmid">23296063</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>M</given-names></name><name><surname>Park</surname><given-names>EY</given-names></name></person-group><article-title>Effects of breast health education conducted by trained breast cancer survivors</article-title><source>J Adv Nurs</source><year>2012</year><volume>68</volume><issue>5</issue><fpage>1100</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2648.2011.05815.x</pub-id><pub-id pub-id-type="pmid">21880060</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bebis</surname><given-names>H</given-names></name><name><surname>Reis</surname><given-names>N</given-names></name><name><surname>Yavan</surname><given-names>T</given-names></name><name><surname>Bayrak</surname><given-names>D</given-names></name><name><surname>Unal</surname><given-names>A</given-names></name><name><surname>Bodur</surname><given-names>S</given-names></name></person-group><article-title>Effect of health education about cervical cancer and papanicolaou testing on the behavior, knowledge, and beliefs of Turkish women</article-title><source>Int J Gynecol Cancer</source><year>2012</year><volume>22</volume><issue>8</issue><fpage>1407</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1097/IGC.0b013e318263f04c</pub-id><pub-id pub-id-type="pmid">22932261</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCree-Hale</surname><given-names>R</given-names></name><name><surname>Hale</surname><given-names>TM</given-names></name><name><surname>Rutley</surname><given-names>KR</given-names></name><name><surname>Aung</surname><given-names>M</given-names></name><name><surname>Jolly</surname><given-names>PE</given-names></name></person-group><article-title>Evaluating a theory-based health education intervention to improve awareness of prostate cancer among men in Western Jamaica</article-title><source>West Indian Med J</source><year>2012</year><volume>61</volume><issue>6</issue><fpage>580</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">23441351</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siddique</surname><given-names>I</given-names></name><name><surname>Mitchell</surname><given-names>DA</given-names></name></person-group><article-title>The impact of a community-based health education programme on oral cancer risk factor awareness among a Gujarati community</article-title><source>Br Dent J</source><year>2013</year><volume>215</volume><issue>4</issue><fpage>E7</fpage><pub-id pub-id-type="doi">10.1038/sj.bdj.2013.829</pub-id><pub-id pub-id-type="pmid">23969680</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alidosti</surname><given-names>M</given-names></name><name><surname>Sharifirad</surname><given-names>GR</given-names></name><name><surname>Golshiri</surname><given-names>P</given-names></name><name><surname>Azadbakht</surname><given-names>L</given-names></name><name><surname>Hasanzadeh</surname><given-names>A</given-names></name><name><surname>Hemati</surname><given-names>Z</given-names></name></person-group><article-title>An investigation on the effect of gastric cancer education based on Health Belief Model on knowledge, attitude and nutritional practice of housewives</article-title><source>Iran J Nurs Midwifery Res</source><year>2012</year><volume>17</volume><issue>4</issue><fpage>256</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">23833623</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pentenero</surname><given-names>M</given-names></name><name><surname>Chiecchio</surname><given-names>A</given-names></name><name><surname>Gandolfo</surname><given-names>S</given-names></name></person-group><article-title>Impact of academic and continuing education on oral cancer knowledge, attitude and practice among dentists in north-western Italy</article-title><source>J Cancer Educ</source><year>2014</year><volume>29</volume><issue>1</issue><fpage>151</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1007/s13187-013-0562-1</pub-id><pub-id pub-id-type="pmid">24092533</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueland</surname><given-names>AS</given-names></name><name><surname>Hornung</surname><given-names>PA</given-names></name><name><surname>Greenwald</surname><given-names>B</given-names></name></person-group><article-title>Colorectal cancer prevention and screening: a Health Belief Model-based research study to increase disease awareness</article-title><source>Gastroenterol Nurs</source><year>2006</year><volume>29</volume><issue>5</issue><fpage>357</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1097/00001610-200609000-00002</pub-id><pub-id pub-id-type="pmid">17038836</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheinfeld Gorin</surname><given-names>S</given-names></name><name><surname>Gemson</surname><given-names>D</given-names></name><name><surname>Ashford</surname><given-names>A</given-names></name><name><surname>Bloch</surname><given-names>S</given-names></name><name><surname>Lantigua</surname><given-names>R</given-names></name><name><surname>Ahsan</surname><given-names>H</given-names></name><etal/></person-group><article-title>Cancer education among primary care physicians in an underserved community</article-title><source>Am J Prev Med</source><year>2000</year><volume>19</volume><issue>1</issue><fpage>53</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/S0749-3797(00)00153-7</pub-id><pub-id pub-id-type="pmid">10865164</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>NE</given-names></name><name><surname>Ross</surname><given-names>J</given-names></name><name><surname>Sumner</surname><given-names>W</given-names></name><name><surname>Nease</surname><given-names>RF</given-names><suffix>Jr</suffix></name><name><surname>Littenberg</surname><given-names>B</given-names></name></person-group><article-title>The effect of an educational intervention on the perceived risk of breast cancer</article-title><source>J Gen Intern Med</source><year>1996</year><volume>11</volume><issue>2</issue><fpage>92</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1007/BF02599584</pub-id><pub-id pub-id-type="pmid">8833016</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="other">Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2012: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2012. doi:10.3322/caac.20143.</mixed-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>AK</given-names></name><name><surname>Melton</surname><given-names>LJ</given-names><suffix>3rd</suffix></name><name><surname>Petersen</surname><given-names>GM</given-names></name><name><surname>Timmons</surname><given-names>LJ</given-names></name><name><surname>Vege</surname><given-names>SS</given-names></name><name><surname>Harmsen</surname><given-names>WS</given-names></name><etal/></person-group><article-title>Changing trends in the incidence, stage, survival, and screen-detection of colorectal cancer: a population-based study</article-title><source>Clin Gastroenterol Hepatol</source><year>2005</year><volume>3</volume><issue>2</issue><fpage>150</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/S1542-3565(04)00664-0</pub-id><pub-id pub-id-type="pmid">15704049</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="other">Shi JF. A cost-effectiveness analysis of China cervical cancer screening protocol for rural farmers. PhD thesis. China union Medical University. 2009.</mixed-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hady</surname><given-names>HR</given-names></name><name><surname>So&#x00142;datow</surname><given-names>M</given-names></name><name><surname>Lukaszewicz</surname><given-names>J</given-names></name><name><surname>Luba</surname><given-names>M</given-names></name><name><surname>Pierko</surname><given-names>J</given-names></name><name><surname>My&#x0015b;liwiec</surname><given-names>P</given-names></name><etal/></person-group><article-title>Surgical treatment of malignant and benign colorectal neoplasms based on authors&#x02019; clinical data</article-title><source>Adv Clin Exp Med</source><year>2013</year><volume>22</volume><issue>2</issue><fpage>219</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">23709378</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>CH</given-names></name><name><surname>Weng</surname><given-names>BC</given-names></name><name><surname>Wu</surname><given-names>CC</given-names></name><name><surname>Yang</surname><given-names>SF</given-names></name><name><surname>Wu</surname><given-names>DC</given-names></name><name><surname>Wang</surname><given-names>YC</given-names></name></person-group><article-title>Apigenin has anti-atrophic gastritis and anti-gastric cancer progression effects in Helicobacter pylori-infected Mongolian gerbils</article-title><source>J Ethnopharmacol</source><year>2014</year><volume>151</volume><issue>3</issue><fpage>1031</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2013.11.040</pub-id><pub-id pub-id-type="pmid">24374236</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lansdorp-Vogelaar</surname><given-names>I</given-names></name><name><surname>Sharp</surname><given-names>L</given-names></name></person-group><article-title>Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention</article-title><source>Best Pract Res Clin Gastroenterol</source><year>2013</year><volume>27</volume><issue>6</issue><fpage>933</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.bpg.2013.09.005</pub-id><pub-id pub-id-type="pmid">24182612</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>QY</given-names></name><name><surname>Chen</surname><given-names>HM</given-names></name><name><surname>Chen</surname><given-names>YX</given-names></name><name><surname>Wang</surname><given-names>YC</given-names></name><name><surname>Wang</surname><given-names>ZH</given-names></name><name><surname>Tang</surname><given-names>JT</given-names></name><etal/></person-group><article-title>Folic acid prevents the initial occurrence of sporadic colorectal adenoma in Chinese older than 50&#x000a0;years of age: a randomized clinical trial</article-title><source>Cancer Prev Res (Phila)</source><year>2013</year><volume>6</volume><issue>7</issue><fpage>744</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1158/1940-6207.CAPR-13-0013</pub-id><pub-id pub-id-type="pmid">23682073</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farrell</surname><given-names>GC</given-names></name><name><surname>Chan</surname><given-names>HL</given-names></name><name><surname>Yuen</surname><given-names>MF</given-names></name><name><surname>Amarapurkar</surname><given-names>DN</given-names></name><name><surname>Chutaputti</surname><given-names>A</given-names></name><name><surname>Fan</surname><given-names>JG</given-names></name><etal/></person-group><article-title>Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements</article-title><source>J Gastroenterol Hepatol</source><year>2010</year><volume>25</volume><issue>4</issue><fpage>657</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1746.2009.06167.x</pub-id><pub-id pub-id-type="pmid">20492323</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Lu</surname><given-names>TX</given-names></name></person-group><source>Nasopharyngeal caner trends and prevention strategies. Proceedings of the 13th Annual Conference of China Science and Technology Association: 21 September 2011</source><year>2011</year><publisher-loc>China Tianjin</publisher-loc><publisher-name>China Association for Science and Technology, Tianjin Municipal People's Government</publisher-name></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname><given-names>LF</given-names></name></person-group><article-title>Effectiveness and implications of colorectal cancer screening in urban communities</article-title><source>Chin Prim Health Care</source><year>2012</year><volume>26</volume><issue>9</issue><fpage>34</fpage><lpage>5</lpage></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>YD</given-names></name><name><surname>Qu</surname><given-names>LY</given-names></name><name><surname>Guan</surname><given-names>LZ</given-names></name><name><surname>Wang</surname><given-names>GQ</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Peng</surname><given-names>DY</given-names></name><etal/></person-group><article-title>Colorectal cancer screening in Beijing community: effectiveness and problems</article-title><source>Chin J Prim Health Care</source><year>2007</year><volume>10</volume><issue>19</issue><fpage>1586</fpage><lpage>8</lpage></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>KY</given-names></name><name><surname>Ma</surname><given-names>WL</given-names></name><name><surname>Ma</surname><given-names>XY</given-names></name></person-group><article-title>Management of community-based cancer prevention and control</article-title><source>China Cancer</source><year>2014</year><volume>23</volume><issue>1</issue><fpage>23</fpage><lpage>5</lpage></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honein-Abouhaidar</surname><given-names>GN</given-names></name><name><surname>Kastner</surname><given-names>M</given-names></name><name><surname>Vuong</surname><given-names>V</given-names></name><name><surname>Perrier</surname><given-names>L</given-names></name><name><surname>Rabeneck</surname><given-names>L</given-names></name><name><surname>Tinmouth</surname><given-names>J</given-names></name><etal/></person-group><article-title>Benefits and barriers to participation in colorectal cancer screening: a protocol for a systematic review and synthesis of qualitative studies</article-title><source>BMJ Open</source><year>2014</year><volume>4</volume><issue>2</issue><fpage>e004508</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2013-004508</pub-id><pub-id pub-id-type="pmid">24578543</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cadman</surname><given-names>L</given-names></name><name><surname>Ashdown-Barr</surname><given-names>L</given-names></name><name><surname>Waller</surname><given-names>J</given-names></name><name><surname>Szarewski</surname><given-names>A</given-names></name></person-group><article-title>Attitudes towards cytology and human papillomavirus self-sample collection for cervical screening among Hindu women in London, UK: a mixed methods study</article-title><source>J Fam Plann Reprod Health Care</source><year>2015</year><volume>41</volume><issue>1</issue><fpage>38</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1136/jfprhc-2013-100705</pub-id><pub-id pub-id-type="pmid">24521934</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liss</surname><given-names>DT</given-names></name><name><surname>Baker</surname><given-names>DW</given-names></name></person-group><article-title>Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care</article-title><source>Am J Prev Med</source><year>2014</year><volume>46</volume><issue>3</issue><fpage>228</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.amepre.2013.10.023</pub-id><pub-id pub-id-type="pmid">24512861</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozanne</surname><given-names>EM</given-names></name><name><surname>Howe</surname><given-names>R</given-names></name><name><surname>Omer</surname><given-names>Z</given-names></name><name><surname>Esserman</surname><given-names>LJ</given-names></name></person-group><article-title>Development of a personalized decision aid for breast cancer risk reduction and management</article-title><source>BMC Med Inform Decis Mak</source><year>2014</year><volume>14</volume><fpage>4</fpage><pub-id pub-id-type="doi">10.1186/1472-6947-14-4</pub-id><pub-id pub-id-type="pmid">24422989</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmer</surname><given-names>Z</given-names></name><name><surname>Kwong</surname><given-names>J</given-names></name></person-group><article-title>Socioeconomic status and health among older adults in rural and urban China</article-title><source>J Aging Health</source><year>2004</year><volume>16</volume><issue>1</issue><fpage>44</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1177/0898264303260440</pub-id><pub-id pub-id-type="pmid">14979310</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>S</given-names></name><name><surname>Chai</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>P</given-names></name><etal/></person-group><article-title>Toward integrated and sustainable prevention against diabetes in rural China: study rationale and protocol of eCROPS</article-title><source>BMC Endocr Disord</source><year>2013</year><volume>13</volume><issue>1</issue><fpage>28</fpage><pub-id pub-id-type="doi">10.1186/1472-6823-13-28</pub-id><pub-id pub-id-type="pmid">23919331</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Carroll Bantum</surname><given-names>E</given-names></name><name><surname>Albright</surname><given-names>CL</given-names></name><name><surname>White</surname><given-names>KK</given-names></name><name><surname>Berenberg</surname><given-names>JL</given-names></name><name><surname>Layi</surname><given-names>G</given-names></name><name><surname>Ritter</surname><given-names>PL</given-names></name><etal/></person-group><article-title>Surviving and thriving with cancer using a web-based health behavior change intervention: randomized controlled trial</article-title><source>J Med Internet Res</source><year>2014</year><volume>16</volume><issue>2</issue><fpage>e54</fpage><pub-id pub-id-type="doi">10.2196/jmir.3020</pub-id><pub-id pub-id-type="pmid">24566820</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>WM</given-names></name><name><surname>Bloch</surname><given-names>M</given-names></name><name><surname>Hesse</surname><given-names>BW</given-names></name><name><surname>McDonald</surname><given-names>PG</given-names></name><name><surname>Nebeling</surname><given-names>L</given-names></name><name><surname>O&#x02019;Connell</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Behavioral research in cancer prevention and control: alook to the future</article-title><source>Am J Prev Med</source><year>2014</year><volume>46</volume><issue>3</issue><fpage>303</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.amepre.2013.10.004</pub-id><pub-id pub-id-type="pmid">24512871</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawkes</surname><given-names>AL</given-names></name><name><surname>Chambers</surname><given-names>SK</given-names></name><name><surname>Pakenham</surname><given-names>KI</given-names></name><name><surname>Patrao</surname><given-names>TA</given-names></name><name><surname>Baade</surname><given-names>PD</given-names></name><name><surname>Lynch</surname><given-names>BM</given-names></name><etal/></person-group><article-title>Effects of a telephone-delivered multiple health behavior change intervention (Can Change) on health and behavioral outcomes in survivors of colorectal cancer: a randomized controlled trial</article-title><source>J Clin Oncol</source><year>2013</year><volume>31</volume><issue>18</issue><fpage>2313</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1200/JCO.2012.45.5873</pub-id><pub-id pub-id-type="pmid">23690410</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>WK</given-names></name></person-group><article-title>Control the spread of HIV/STI by incorporating prevention with treatment</article-title><source>J Chin AIDS/STD Pre Cont</source><year>1996</year><volume>2</volume><issue>6</issue><fpage>248</fpage><lpage>53</lpage></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Ministry of Health of the People&#x02019;s Republic of China</collab></person-group><source>China Health Statistic Annual</source><year>2009</year><publisher-loc>Beijing</publisher-loc><publisher-name>Peking Union Medical College Press</publisher-name></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name></person-group><article-title>The analysis of human resource against chronic disease prevention department of Langfang in 2010</article-title><source>China foreign medical treatment</source><year>2011</year><volume>13</volume><fpage>68</fpage></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>NX</given-names></name><name><surname>Ren</surname><given-names>XH</given-names></name><name><surname>Tang</surname><given-names>M</given-names></name></person-group><article-title>Patients intention of visiting doctor and community health service</article-title><source>J China Health Serv Manag</source><year>2001</year><volume>2</volume><fpage>101</fpage><lpage>2</lpage></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rena</surname><given-names>W</given-names></name><name><surname>Bonnie</surname><given-names>G</given-names></name></person-group><source>DPP Lifestyle Change Program Manual of Operation</source><year>1996</year><publisher-loc>Pittsburgh</publisher-loc><publisher-name>University of Pittsburgh</publisher-name></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Chai</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Xie</surname><given-names>S</given-names></name><name><surname>Liang</surname><given-names>H</given-names></name><etal/></person-group><article-title>A smart web aid for preventing diabetes in rural china: preliminary findings and lessons</article-title><source>J Med Internet Res</source><year>2014</year><volume>16</volume><issue>4</issue><fpage>e98</fpage><pub-id pub-id-type="doi">10.2196/jmir.3228</pub-id><pub-id pub-id-type="pmid">24691410</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moher</surname><given-names>D</given-names></name><name><surname>Hopewell</surname><given-names>S</given-names></name><name><surname>Schulz</surname><given-names>KF</given-names></name><name><surname>Montori</surname><given-names>V</given-names></name><name><surname>G&#x000f8;tzsche</surname><given-names>PC</given-names></name><name><surname>Devereaux</surname><given-names>PJ</given-names></name><etal/></person-group><article-title>Consolidated Standards of Reporting Trials Group: CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials</article-title><source>J Clin Epidemiol</source><year>2010</year><volume>63</volume><issue>8</issue><fpage>e1</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2010.03.004</pub-id><pub-id pub-id-type="pmid">20346624</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norat</surname><given-names>T</given-names></name><name><surname>Aune</surname><given-names>D</given-names></name><name><surname>Chan</surname><given-names>D</given-names></name><name><surname>Romaguera</surname><given-names>D</given-names></name></person-group><article-title>Fruits and vegetables: updating the epidemiologic evidence for the WCRF/AICR lifestyle recommendations for cancer prevention</article-title><source>Cancer Treat Res</source><year>2014</year><volume>159</volume><fpage>35</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1007/978-3-642-38007-5_3</pub-id><pub-id pub-id-type="pmid">24114473</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vainio</surname><given-names>H</given-names></name><name><surname>Weiderpass</surname><given-names>E</given-names></name></person-group><article-title>Fruit and vegetables in cancer prevention</article-title><source>Nutr Cancer</source><year>2006</year><volume>54</volume><issue>1</issue><fpage>111</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1207/s15327914nc5401_13</pub-id><pub-id pub-id-type="pmid">16800779</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cundill</surname><given-names>G</given-names></name><name><surname>Cumming</surname><given-names>GS</given-names></name><name><surname>Biggs</surname><given-names>D</given-names></name><name><surname>Fabricius</surname><given-names>C</given-names></name></person-group><article-title>Soft Systems Thinking and Social Learning for Adaptive Management</article-title><source>Conserv Biol</source><year>2012</year><volume>26</volume><issue>1</issue><fpage>13</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1111/j.1523-1739.2011.01755.x</pub-id><pub-id pub-id-type="pmid">22010884</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi-pin</surname><given-names>ZHU</given-names></name><name><surname>Miao</surname><given-names>YU</given-names></name><name><surname>Fu-qiang</surname><given-names>YANG</given-names></name><name><surname>Jiang-dong</surname><given-names>ZHOU</given-names></name><name><surname>Jun</surname><given-names>YANG</given-names></name><name><surname>Qi</surname><given-names>ZHAO</given-names></name><etal/></person-group><article-title>The feasibility of developing a syndromic surveillance system in rural China: A case study of two counties in Jiangxi province (in Chinese)</article-title><source>Chin J Health Pol</source><year>2013</year><volume>6</volume><issue>4</issue><fpage>60</fpage><lpage>5</lpage></element-citation></ref></ref-list></back></article>